#Ireland #Medical Devices #Galway #Quasar Medical #Nordson Medical

Quasar Medical Expands Global Reach with Strategic Acquisition

Quasar Medical, a leading entity in the field of interventional and minimally invasive medical devices, has taken a significant step forward by completing its acquisition of Nordson Corporation's design and development contract manufacturing facilities located in Galway, Ireland, and Tecate, Mexico. This acquisition is set to enrich Quasar's global Contract Development and Manufacturing Organization (CDMO) platform, leading to a more substantial offering for original equipment manufacturers (OEMs) in the medical sector.

Transformative Development for Quasar

The evolution of Quasar into a fully integrated CDMO signifies a crucial developmental phase in its growth strategy. With this expansion, Quasar aims to provide comprehensive solutions that cover the entire spectrum from concept to commercialization, ensuring innovative and efficient delivery to customers worldwide. The integration is not just about expanding physical assets; it involves augmenting the workforce with nearly 200 skilled professionals, including development engineers and technicians, which enhances both its innovation capacity and operational efficiency.

As CEO Alex Wallstein articulates, “This strategic acquisition marks an exciting new chapter for Quasar and the customers we serve.” By fusing Quasar's manufacturing prowess with the specialized design and development capabilities of the Galway and Tecate teams, the company is poised to enhance its global footprint while creating a robust platform for innovation and collaboration.

Enhancing Global Presence

The acquisition strengthens Quasar's international presence, especially with the addition of two FDA-registered, ISO 13485-certified facilities located in key medical technology hubs—Europe and North America. The Galway facility will become a center of innovation focusing on product design, prototyping, and clinical innovations for complex medical technologies such as extrusions, braiding, balloons, and catheters. Meanwhile, the Tecate site will deliver cost-effective, high-volume manufacturing solutions that facilitate the transition from development stages to market-ready products.

COO Aviel Bohnik stated, “This is a pivotal milestone that positions Quasar as a strategic partner to our customers—not just a manufacturer.” By integrating Nordson's capabilities, Quasar enhances its service offerings, providing a unique blend of upstream innovation and downstream scalability. This positions the company to accelerate time-to-market for its clients, making Quasar an even more competitive player in the medical device industry.

Comprehensive Solutions for Customers

The strategic integration of Nordson Medical allows Quasar Medical to present a seamless end-to-end solution for developing intricate interventional devices. Enhanced offerings include:

• - Advanced Product Development and Rapid Prototyping: Leveraging the expertise in Galway, Quasar can now expedite early-stage development to ensure innovative solutions.
• - Design for Manufacturing Expertise: This encompasses deep knowledge in developing balloon catheters and shafts, complemented by thorough testing capabilities.
• - Scalable Manufacturing and Assembly in Tecate: The facility supports molded products, coatings, packaging, and implements automated processes to meet high-volume demands.

Through this acquisition, Quasar significantly broadens its cleanroom operations and deepens its technical expertise in specialized areas such as extrusions and delivery systems, thus creating ample growth opportunities at both sites. The proximity to customers in North America and Europe empowers Quasar to deliver improved development speeds, higher quality control, and more cost-efficient manufacturing options.

Seamless Collaboration and Growth

Quasar is committed to ensuring a smooth integration process for employees, customers, and suppliers throughout this transition with Nordson. This collaboration is expected to be essential for maintaining high operational standards and achieving the shared goal of delivering high-value solutions to customers effectively.

About Quasar Medical

Quasar Medical operates as a comprehensive CDMO delivering full-spectrum solutions for interventional and minimally invasive medical devices. With 11 facilities worldwide and a workforce of over 4,300 across Asia, North America, and Europe, it specializes in catheter systems, balloon technologies, and complex assemblies. The company emphasizes cost-effective scalability and swift market delivery, working under strict ISO 13485:2016 and cGMP regulations. For more information about Quasar Medical, visit www.quasarmedical.com.